These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10464884)

  • 1. Does an inhaled beta-adrenergic or anticholinergic agent improve gas exchange at rest and during exercise in patients with COPD?
    Teramoto S; Ouchi Y
    Respir Med; 1999 Mar; 93(3):222-3. PubMed ID: 10464884
    [No Abstract]   [Full Text] [Related]  

  • 2. A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD.
    Teramoto S; Fukuchi Y; Ouchi Y
    Chest; 1996 Jun; 109(6):1666-7. PubMed ID: 8769538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current strategy of bronchodilator therapy for chronic obstructive pulmonary disease (COPD)].
    Teramoto S
    Nihon Rinsho; 1999 Sep; 57(9):2051-5. PubMed ID: 10497405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents].
    Nishimura K; Ikeda A; Koyama H; Tsukino M; Hajiro T; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():75-8. PubMed ID: 9216189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticholinergic drugs in the therapy of obstructive airway diseases].
    Windt R
    Med Monatsschr Pharm; 2011 Apr; 34(4):130-7. PubMed ID: 21528530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD].
    Lode H
    Internist (Berl); 1999 Jan; 40(1):114. PubMed ID: 10086312
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of inhaled oxitropium bromide, an anticholinergic drug, on pulmonary hemodynamics in patients with chronic obstructive pulmonary diseases].
    Saito S; Miyamoto K; Aida A; Saito H; Sato F; Tsujino I; Nakano T; Nishimura M; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Sep; 33(9):924-9. PubMed ID: 8538086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticholinergic drugs in therapy of chronic obstructive lung disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Med Klin (Munich); 2000 Oct; 95(10):552-8. PubMed ID: 11092168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent progress on the therapy for chronic obstructive pulmonary disease (COPD)--usefulness and practice of the step-by-step pharmacologic therapy].
    Ishii T; Matsuse T
    Nihon Rinsho; 1999 Sep; 57(9):2035-40. PubMed ID: 10497402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
    Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta2-agonists and anticholinergic agents].
    Madsen FF
    Ugeskr Laeger; 1997 Mar; 159(10):1470-1. PubMed ID: 9082639
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of inhaled dry powder ipratropium bromide on recovery from exercise of horses with COPD.
    Duvivier DH; Bayly WM; Votion D; Vandenput S; Art T; Farnir F; Lekeux P
    Equine Vet J; 1999 Jan; 31(1):20-4. PubMed ID: 9952325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease.
    Teramoto S; Fukuchi Y; Orimo H
    Chest; 1993 Jun; 103(6):1774-82. PubMed ID: 8404100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the calcium antagonist tiapamil on pulmonary gas exchange in patients with chronic obstructive pulmonary disease who receive salbutamol.
    Gugger M; Crivelli AM; Galeazzi RL; Bachofen H
    Clin Pharmacol Ther; 1985 Jul; 38(1):96-100. PubMed ID: 4006380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
    Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
    Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF
    Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease.
    Mulloy E; McNicholas WT
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1030-6. PubMed ID: 8214921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects of anticholinergic agents].
    Friedman M
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of inhaled anticholinergic drug on lung function, dyspnea, and exercise capacity in patients with chronic obstructive pulmonary disease.
    Teramoto S; Matsuse T; Sudo E; Ohga E; Katayama H; Suzuki M; Ouchi Y; Fukuchi Y
    Intern Med; 1996 Oct; 35(10):772-8. PubMed ID: 8933184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.